Also, we demonstrated that treatment of toxoplasma-infected animals with surrogate marker-specific non-exhausted CD4 population reversed CD8 exhaustion and controlled the reactivation of latent infection (17). Here, CD8A is linked to disease arising from reactivation of latent virus.